Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include BLU-285, BLU 554, and BLU-667.
$95.78 +3.77 (4.10%)
As of 03/05/2021 15:59:14 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.